Extended, 3-year, exenatide therapy shows sustainable effects on beta cell disposition index in metformin treated patients with type 2 diabetes

Mathias C. Bunck, Anja Corner, Björn Eliasson, Robert J. Heine, Rimma M. Shaginian, Marja-Riitta Taskinen, Ulf Smith, Hannele Yki-Järvinen, Michaela Diamant

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Pages (from-to)-
Number of pages1
Publication statusPublished - 2010
MoE publication typeA1 Journal article-refereed

Cite this